SCHEMBL7668355

SCHEMBL7668355

O=C=C(Nc1cccc(OCCCC(=O)O)c1)c1ccc2nc(Nc3cccnc3)oc2c1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.42
EPHX2 P34913 2/20 0.42
MAPK1 P28482 2/20 0.41
TSHR P16473 1/20 0.41
MAPT P10636 3/20 0.40
ALDH1A1 P00352 1/20 0.39
FABP1 P07148 1/20 0.38
NAMPT P43490 1/20 0.38
KDM4E B2RXH2 1/20 0.37
TLR9 Q9NR96 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
KMT2A Q03164 1/20 0.37
MCL1 Q07820 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7657273 0.85 EPHX2 (0.49) HDAC6EPHX2MAPK1TSHRALDH1A1
SCHEMBL7668364 0.80 HDAC6 (0.38) HDAC6EPHX2MAPK1TSHRALDH1A1
SCHEMBL6597373 0.77 HDAC6 (0.42) HDAC6MAPT
SCHEMBL6597368 0.77 NPC1 (0.47) HDAC6MAPK1TSHRMAPTALDH1A1
SCHEMBL6598330 0.76 P2RY14 (0.49) HDAC6EPHX2KMT2A
SCHEMBL3866405 0.76 RAB9A (0.45) HDAC6MAPTALDH1A1CYP1A2CYP2C9
SCHEMBL6592188 0.74 CYSLTR1 (0.44) HDAC6MAPTTLR9KMT2A
SCHEMBL7665064 0.73 LCK (0.48) MAPTALDH1A1KDM4EKMT2ANPC1
SCHEMBL6594493 0.71 HDAC6 (0.52) HDAC6EPHX2KMT2A
SCHEMBL7659834 0.71 KDM4E (0.52) HDAC6MAPK1MAPTALDH1A1NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1144393-A3 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITOR AstraZeneca AB (SE) 2002-09-11 EP disclosed
US-6441012-B1 BENZOXAZOLE OR BENZTHIAZOLE DERIVATIVES FOR INHIBITING THE INTERACTION BETWEEN CELLULAR ADHESION MOLECULES AND/OR FIBRONECTIN AND THE INTERGRIN RECEPTOR ASTRAZENECA AB (SE) 2002-08-27 US disclosed
EP-1144393-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITOR AstraZeneca AB (SE) 2001-10-17 EP disclosed
WO-2000005224-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITOR ASTRAZENECA AB (SE) 2000-02-03 WO disclosed